Annovis Bio, Inc. (ANVS) Tops Q1 EPS by 6c

Annovis Bio, Inc. (NYSE: ANVS) reported Q1 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Independence Realty Trust (IRT) files mixed shelf
• Super League Enterprise (SLE) files for 1.07M share offering by selling stockholders